EQS-News: Dermapharm Holding SE / Key word: Investment/Takeover
Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit
13.06.2023 / 15:15. | June 13, 2023
EQS Voting Rights Announcement: Dermapharm Holding SE
Dermapharm Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of. | May 31, 2023
After good business figures, Dermapharm shares briefly climbed to a high since September 2022 on Monday at 46.70 euros. The shares of the specialist for dermatology and allergology gained at times. | May 15, 2023
Drugmaker Dermapharm has started the new year with significantly higher sales and profits in its day-to-day business. The main growth impulses in the opening quarter resulted from the acquisition of. | May 15, 2023
Alexander Thiel from Jefferies retains his positive opinion on the stock with a Buy rating. The target price is unchanged and still at EUR 65. | May 15, 2023